Diagnosis and management of iron-induced heart disease in Cooley's anemia

Annals of the New York Academy of Sciences

Volumn 850, Issue , 1998, Pages 242-250

  Jessup, Mariell ^a   Manno, Catherine S ^b  

^a ALLEGHENY UNIVERSITY HOSPITALS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; IRON; VASODILATOR AGENT;

ANEMIA; BETA THALASSEMIA; BLOOD TRANSFUSION; CONFERENCE PAPER; DIASTOLE; ELECTROCARDIOGRAM; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART PERFORMANCE; HORMONAL REGULATION; HUMAN; IRON CHELATION; IRON OVERLOAD; PERICARDITIS; THALASSEMIA MAJOR;

EID: 0031820514     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10481.x     Document Type: Conference Paper

References (32)

1. ENGLE, M. A., M. ERLANDSON & C. H. SMITH. 1964. Late cardiac complications of chronic, severe refractory anemia with hemochromatosis. Circulation 30: 698-705.
2. EHLERS, K. H., A. R. LEVIN, A. L. MARKENSON et al. 1980. Longitudinal study of cardiac function in thalassemia major. Ann. N.Y. Acad. Sci. 344: 397-404.
3. ZURLO, M. G., P. DESTEFANO, C. BORGNA-PIGNATTI et al. 1989. Survival and causes of death in thalassemia major. Lancet 2: 27-30.
4. BRITTENHAM, G. M., P. M. GRIFFTTH, A. W. NIENHUIS et al. 1994. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N. Engl. J. Med. 331: 567-73.
5. OLIVIERI, N. F., D. G. NATHAN, J. H. MACMILLAN et al. 1994. Survival in medically treated patients with homozygous β-Thalassemia. N. Engl. J. Med. 331: 574-578.
6. RICHARDSON, M. E., R. N. MATTHEWS, J. F. ALISON et al. 1993. Prevention of heart disease by subcutaneous deferoxamine in patients with thalassemia major. Aust. N.Z. J. Med. 23: 656-661.
7. CRISARU, D., E. A. RACHMILEWITZ, M. MOSSERI et al. 1990. Cardiopulmonary assessment in βthalassemia major. Chest 98: 1138-1142.
8. KREMASTINOS, D. T., D. P. TSIAPRAS, G. A. TSETSOS et al. 1993. Left ventricular diastolic doppler characteristics in β-Thalassemia major. Circulation 88: 1127-1135.
9. LATTANZI, F., P. BELLOTTI, E. PICANO et al. 1993. Quantitative ultrasonic analysis of myocardium in patients with thalassemia major and iron overload. Circulation 87: 748-754.
10. DESIDERI, A., G. SCATTOLIN, A. GABELLINI et al. 1994. Left ventricular function in thalassemia major: Protective effect of deferoxamine. Can. J. Cardiol. 10: 93-96.
11. BAHL, V. K., O. P. MALHOTRA, D. KUMAR et al. 1992. Noninvasive assessment of systolic and diastolic left ventricular function in patients with chronic severe anemia: A combined M-mode, two-dimensional, and Doppler echocardiographic study. Am. Heart J. 124: 1516-1523.
12. FITCHETT, D. H., D. J. COLTART, W. A. LITTLER et al. 1980. Cardiac involvement in secondary hemochromatosis: a catheter biopsy study and analysis of myocardium. Cardiovasc. Res. 14: 719-724.
13. BUJA, C. M. & W. C. ROBERTS. 1971. Iron in the heart. Am. J. Med. 51: 209-219.
14. SCHELLHAMMER, P. F., M. A. ENGLE & T. W. HAGSTROM. 1967. Histochemical studies of the myocardium and conduction tissue in acquired iron storage disease. Circulation 35: 631-637.
15. KREMASTINOS, D. T., G. TINIAKOS, G. N. THEODORAKIS et al. 1995. Myocarditis in β-thalassemia major. A cause of heart failure. Circulation 91: 66-71.
16. VECCHIO, C. & G. DERCHI. 1995. Management of cardiac complications in patients with thalassemia major. Sem. Hematol. 32: 288-296.
17. BOROW, K. M., R. PROPPER, F. Z. BIERMAN et al. 1982. The left ventricular end-systolic pressure-dimension relation in patients with thalassemia major. A new non-invasive method for assessing contractile state. Circulation 66: 980-985.
18. LEON, M. B., J. S. BORER, S. L. BACHARACH et al. 1979. Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron-overload N. Engl. J. Med. 301: 1143-1148.
19. GIBBONS, R. J., K. L. LEE, F. COBB et al. 1981. Ejection fraction response to exercise in patients with chest pain and normal coronary arteriograms. Circulation 64: 952-958.
20. MANCINI, D. M., H. EISEN, W. KUSSMAUL et al. 1991. Value of peak oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83: 778-783.
21. O'CONNELL, J. B., R. C. BOURGE, M. R. COSTANZO-NORDIN et al. 1992. Cardiac transplantation: Recipient selection, donor procurement, and medical follow-up: A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology. American Heart Association. Circulation 86: 1061-1079.
22. MARCUS, R. E., S. C. DAVIES, H. M. BANTOCK et al. 1984. Deferoxamine to improve cardiac function in iron-overloaded patients with thalassemia major. Lancet 1: 392-393.
23. POLITI, A., M. STICCA & M. GALL. 1995. Reversal of haemochromatic cardiomyopathy in β-Thalassemia by chelation therapy. Br. Heart J. 73: 486-487.
24. MELONI, C., M. MOROSETTI, L. MESCHINI et al. 1994. Isolated ultrafiltration in refractory heart failure on patients with Cooley's anemia. Artific. Cells Blood Subst. Immobil. Biotech. 22: 109-113.
25. OLIVIERI, N. F., P. P. LIU, G. D. SHER et al. 1994. Brief report: Combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous beta-thalassemia. N. Engl. J. Med. 330: 1125-1127.
26. KOERNER, M. M., G. TENDRERICH, K. MINAMI et al. 1997. Heart transplantation for end-stage heart failure caused by iron overload. Br. J. Haematol. 97: 293-296.
27. PACKER, M. 1995. Evolution of the neurohormonal hypothesis to explain the progression of chronic heart failure. Eur. Heart J. 16 (Supplement F): 4-6.
28. LANG, C. C., H. M. MCALPINE & N. KENNEDY. 1995. Effects of lisinopril on congestive heart failure in normotensive patients with diastolic dysfunction but intact systolic function. Eur. J. Clin. Pharmacol. 49: 15-19.
29. PEARSON, H. A., A. R. COHEN, P. V. J. GIARDINA et al. 1996. The changing profile of homozygous β-thalassemia: Demography, ethnicity, and age distribution of current North American patients and changes in two decades. Pediatrics 97: 352-356.
30. FRANCIS, G. S. 1986. Development of arrhythmias in the patient with congestive heart failure: Pathophysiology, prevalence and prognosis. Am. J. Cardiol 57: 3B-7B.
31. GOTTLIEB, S. S. 1989. The use of antiarrhythmic agents in heart failure: Implications of CAST. Am. Heart J. 118: 1074-1077.
32. RUND, D. & E. RACHMILEWITZ. 1995. Thalassemia Major 1995: Older patients, new therapies. Blood Rev. 9: 25-32.